Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JPMY | ISIN: US64131A1051 | Ticker-Symbol: NRC
Tradegate
05.06.25 | 17:16
3,390 Euro
+3,99 % +0,130
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEURONETICS INC Chart 1 Jahr
5-Tage-Chart
NEURONETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,2103,33006.06.
3,2453,27506.06.

Aktuelle News zur NEURONETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoNeuronetics to join Russell 3000 and Russell 2000 indexes3
MoNeuronetics set to join Russell indexes in June1
MoNeuronetics Set to Join Russell 2000 and Russell 3000 Indexes2
28.05.Neuronetics, Inc. - 8-K, Current Report1
NEURONETICS Aktie jetzt für 0€ handeln
14.05.Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month1
06.05.Neuronetics Q1 2025 slides: Combined entity targets profitability by Q3 amid 84% revenue growth2
06.05.Neuronetics, Inc. - 10-Q, Quarterly Report1
06.05.Neuronetics reports mixed Q1 results; initiates Q2 and reaffirms FY25 outlook1
06.05.Neuronetics Reports First Quarter 2025 Financial and Operating Results213MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the "Company" or "Neuronetics") a vertically integrated, commercial stage, medical technology and healthcare company...
► Artikel lesen
06.05.Neuronetics, Inc. - 8-K, Current Report1
05.05.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)71MALVERN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
► Artikel lesen
30.04.Why Neuronetics, Inc. (STIM) is Surging in 20251
31.03.Neuronetics: Evernorth Health Services, a Cigna Company, Expands NeuroStar TMS Coverage for Adolescents Struggling with Depression2
27.03.Neuronetics GAAP EPS of -$0.34 misses by $0.21, revenue of $22.49M misses by $6.58M2
27.03.Neuronetics, Inc. - 10-K, Annual Report1
27.03.Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results194MALVERN, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics") is issuing this press release to update the reporting of its financial results for...
► Artikel lesen
05.03.Canaccord raises Neuronetics stock target to $8, maintains buy rating1
04.03.Neuronetics, Inc. Q4 Loss Increases, Misses Estimates3
04.03.Neuronetics GAAP EPS of -$0.33 misses by $0.09, revenue of $22.49M beats by $3.51M1
04.03.Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results134MALVERN, Pa., March 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics") a vertically integrated, commercial stage, medical technology and healthcare company...
► Artikel lesen
Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1